Is Healthy Life overvalued or undervalued?

As of 14 August 2025, Healthy Life's valuation grade has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently assessed as undervalued. Key ratios include a PE ratio of 42.33, an EV to EBITDA of 28.66, and a ROCE of 16.28%.
In comparison to its peers, Healthy Life's PE ratio is notably lower than Hindustan Unilever's 54.86 and Nestle India's 69.82, both of which are classified as very expensive. Despite a recent decline in stock performance over the past month, Healthy Life has shown remarkable growth over three years with a return of 448.42%, significantly outperforming the Sensex's 35.54% in the same period.